Alfuzosin

Prescription ·Strong evidence ·Reviewed May 2026

Alfuzosin is an alpha-1 adrenergic receptor antagonist with relative selectivity for the lower urinary tract, used for the treatment of signs and symptoms of benign prostatic hyperplasia (BPH). It provides effective relief of LUTS with a low incidence of ejaculatory dysfunction compared to tamsulosin, making it a preferred option for sexually active men.

What it's good for
  • Effective BPH symptom relief (IPSS score improvement)1,3
  • Lower incidence of ejaculatory dysfunction compared to tamsulosin9
  • Once-daily extended-release dosing7,8
  • Well-established safety profile2,5
What to watch for
  • Dizziness
  • Upper respiratory tract infection
  • Headache
  • Known hypersensitivity to alfuzosin1,2
  • Moderate to severe hepatic impairment (Child-Pugh B or C)

The bottom line

Evidence rating strong. Most-documented uses: effective bph symptom relief (ipss score improvement), lower incidence of ejaculatory dysfunction compared to tamsulosin, once-daily extended-release dosing. 10 sources indexed (2001–2026), with 4 interaction records on file.

The science

How it works, mechanistically.

Core mechanism

Blocks alpha-1 adrenergic receptors in the smooth muscle of the prostate, prostatic capsule, and bladder trigone/neck. Although not as subtype-selective as tamsulosin, alfuzosin demonstrates relative uroselectivity in clinical practice, reducing urethral resistance and improving urinary flow rate with modest effects on blood pressure.5

Class
Alpha-1 Blocker / Urologic
Absorption
Water-soluble; take with food
Dosing

Dosing & protocol.

Common range
10 mg once daily immediately after the same meal each day (as prescribed by your physician)
Recommended form
Extended-release tablet (10 mg)

Must be taken immediately after a meal; bioavailability decreases by approximately 50% under fasting conditions. Do not crush, chew, or split extended-release tablets.

Safety

Full safety detail.

Side effects

  • Dizziness
  • Upper respiratory tract infection
  • Headache
  • Fatigue
  • Orthostatic hypotension
  • Intraoperative floppy iris syndrome (IFIS)

Contraindications

  • Known hypersensitivity to alfuzosin1,2
  • Moderate to severe hepatic impairment (Child-Pugh B or C)
  • Concurrent use with potent CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir)
  • Concurrent use with other alpha-1 blockers5
  • QT prolongation or concurrent use of QT-prolonging medications
Interactions

Interaction records.

ModerateCaution

Pine Bark Extract

Alfuzosin is used for LUTS/BPH and can contribute to blood-pressure symptoms in susceptible patients, particularly with other agents that lower vascular tone. Pine bark extract has shown modest reductions in systolic and diastolic blood pressure in some randomized-trial meta-analyses. The combination may increase lightheadedness, fatigue, or near-syncope in patients with low baseline pressure or concurrent antihypertensive therapy.

Recommendation: Start pine bark extract cautiously if you take alfuzosin. Monitor blood pressure and orthostatic symptoms during the first 1-2 weeks, and stop or reduce the supplement if readings drop below your usual range or you feel faint.

ModerateCaution

Alcohol

Alfuzosin is an alpha1 blocker used for urinary symptoms and can contribute to dizziness or low blood pressure in susceptible patients. Alcohol can independently worsen orthostatic hypotension. Combining them may increase lightheadedness, fainting, or falls, especially after dose changes or with other antihypertensive medicines.

Recommendation: Limit alcohol when starting alfuzosin or when your dose changes. If you choose to drink, use small amounts, avoid standing quickly, and pause alcohol if you notice dizziness or near-fainting.

ModerateCaution

L-Arginine

L-Arginine can reduce blood pressure through nitric oxide production. Alfuzosin is generally uroselective but still has clinically relevant blood-pressure considerations, particularly in patients also using antihypertensives. Combining them can cause dizziness or low blood pressure in susceptible users.

Recommendation: If you take alfuzosin, start L-arginine at a low dose and monitor blood pressure for 1-2 weeks. Reduce or stop L-arginine if you become lightheaded, unusually fatigued, or your readings fall below your usual range.

ModerateCaution

L-Citrulline

L-Citrulline increases systemic arginine availability and can modestly lower blood pressure. Alfuzosin can also contribute to blood-pressure symptoms, especially when combined with other agents that lower vascular tone. Together they may cause dizziness, fatigue, or near-fainting.

Recommendation: Do not start L-citrulline and alfuzosin on the same day if you can avoid it. If using both, begin with a low L-citrulline dose, track blood pressure, and stop or reduce it if you become lightheaded.

Sources

Sources, by evidence tier.

Numbered references. Citations throughout the page link here.

Meta-analyses & systematic reviews

2

Randomized controlled trials

2

Reviews & position papers

1
Keep exploring

Deep dives & adjacent profiles.

This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.

Use this with your stack

Alfuzosin in NutriStack.

Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.